BronchoGen presents a cutting-edge diagnostic tool revolutionizing respiratory health assessments. This advanced technology employs a non-invasive approach, utilizing molecular markers to identify and differentiate various respiratory conditions. By analyzing gene expression patterns in the airway, BronchoGen offers precise and early detection of lung diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), and asthma. Its accuracy in distinguishing between benign and malignant lesions in the lungs enhances clinical decision-making, leading to timely interventions and improved patient outcomes. The user-friendly, rapid, and cost-effective nature of BronchoGen positions it as an indispensable asset in the realm of respiratory healthcare, empowering clinicians with actionable insights for personalized treatment strategies.